Literature DB >> 31175577

Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats.

Jianqiang Li1, Zhaorui Liu1, Hongwei Zhao1, Fengxiang Yun1, Zhaoguang Liang1, Dingyu Wang1, Xinbo Zhao1, Jiawei Zhang1, Hai Cang1, Yilun Zou1, Yue Li2.   

Abstract

PURPOSE: It is well known that hyperthyroidism is associated with atrial fibrillation (AF); however, the relationship between hypothyroidism and AF remains controversial.
METHODS: Hypothyroidism was established in rats by two methods: methimazole-induced (MMI) and thyroidectomy (TX). MMI model includes control (n = 10), MMI (n = 10), and MMI + L-thyroxine (T4, n = 10). Methimazole was given intragastrically in MMI and MMI + T4 for 12 weeks, and T4 was added intragastrically in MMI + T4 at week 5. TX model includes sham (n = 10), TX (n = 10), and TX + T4 (n = 10). Four weeks after surgery, rats in TX + T4 received T4 for 8 weeks. Triiodothyronine (T3), T4, and thyroid-stimulating hormone (TSH) were measured. Electrophysiology, tissue structure and function, and protein levels of potassium and L-type calcium channels were assessed in the atria.
RESULTS: Severe changes in the atrial structure of hypothyroid rats were observed. Compared with euthyroid rats, atrial effective refractory period (AERP) in hypothyroid rats was significantly shortened; accordingly, inducibility and duration of AF were considerably increased. Protein levels of minK, Kv1.5, Kv4.2, Kv4.3, Kv7.1, and Cav1.2 were upregulated in hypothyroid rats, whereas there was only a tendency toward increased Kir2.1. Kv11.1 was statistically upregulated in the MMI model and had an increasing tendency in the TX model. Conversely, Kir3.1 and Kir3.4 were downregulated in hypothyroid rats. The above changes could be partially inhibited by T4 treatment.
CONCLUSIONS: AERP shortening due to altered protein levels of ion channels and atrial structural changes increased the susceptibility to AF in hypothyroidism. Thyroid replacement therapy could prevent electrical and structural remodeling under hypothyroid condition.

Entities:  

Keywords:  Atrial fibrillation; Electrical remodeling; Hypothyroidism; Ion channel; Structural remodeling

Mesh:

Substances:

Year:  2019        PMID: 31175577     DOI: 10.1007/s12020-019-01968-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

1.  Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the pro-alpha1(I) collagen gene expression by thyroid hormone receptor.

Authors:  W J Chen; K H Lin; Y S Lee
Journal:  Mol Cell Endocrinol       Date:  2000-04-25       Impact factor: 4.102

Review 2.  Thyroid Disease and the Heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Curr Probl Cardiol       Date:  2015-04-23       Impact factor: 5.200

Review 3.  Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.

Authors:  Nicole Schmitt; Morten Grunnet; Søren-Peter Olesen
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

4.  Different gene expression of potassium channels by thyroid hormone and an antithyroid drug between the atrium and ventricle of rats.

Authors:  Mei Lei Ma; Kenichi Watanabe; Hiroshi Watanabe; Yukio Hosaka; Satoru Komura; Yoshifusa Aizawa; Tadashi Yamamoto
Journal:  Jpn Heart J       Date:  2003-01

Review 5.  Effects of thyroid hormones on the heart.

Authors:  Hernando Vargas-Uricoechea; Anilsa Bonelo-Perdomo; Carlos Hernán Sierra-Torres
Journal:  Clin Investig Arterioscler       Date:  2014-10-22

6.  Preoperative hypothyroidism is a risk factor for postoperative atrial fibrillation in cardiac surgical patients.

Authors:  Berhane Worku; Anthony J Tortolani; Iosif Gulkarov; O Wayne Isom; Irwin Klein
Journal:  J Card Surg       Date:  2015-02-02       Impact factor: 1.620

Review 7.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

Authors:  Brett Burstein; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

8.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

Authors:  Nassir F Marrouche; David Wilber; Gerhard Hindricks; Pierre Jais; Nazem Akoum; Francis Marchlinski; Eugene Kholmovski; Nathan Burgon; Nan Hu; Lluis Mont; Thomas Deneke; Mattias Duytschaever; Thomas Neumann; Moussa Mansour; Christian Mahnkopf; Bengt Herweg; Emile Daoud; Erik Wissner; Paul Bansmann; Johannes Brachmann
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

9.  Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.

Authors:  Youhua Zhang; Eduard I Dedkov; Bianca Lee; Ying Li; Khusbu Pun; A Martin Gerdes
Journal:  J Card Fail       Date:  2014-11-25       Impact factor: 5.712

10.  High-Normal Thyroid-Stimulating Hormone Shows a Potential Causal Association With Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation.

Authors:  Itsuro Morishima; Kenji Okumura; Yasuhiro Morita; Yasunori Kanzaki; Kensuke Takagi; Ruka Yoshida; Hiroaki Nagai; Yoshihiro Ikai; Koichi Furui; Naoki Yoshioka; Hideyuki Tsuboi; Toyoaki Murohara
Journal:  J Am Heart Assoc       Date:  2018-07-12       Impact factor: 5.501

View more
  1 in total

1.  The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats.

Authors:  Mirong Tang; Yan Chen; Fuqing Sun; Liangliang Yan
Journal:  Cardiol Res Pract       Date:  2021-09-27       Impact factor: 1.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.